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Abstract
Introduction
Many viruses have been associated with human breast
cancers, including Epstein-Barr and Cytomegalovirus.
New evidence has revealed the frequent presence of highrisk human papillomavirus (HPV) strains HPV16 and
HPV18 in breast carcinoma biopsies. These findings raise
the question of whether HPV may infect developing cancers and mediate their growth and development, as was
recently observed with oral cancers. The goal of this study
is to test the hypothesis that these high-risk HPV strains
are sufficient to significantly alter phenotypes of already
transformed human breast cancer cell lines.
Materials and methods
A series of in vitro experiments, including proliferation,
adhesion and viability assays, were used to quantify the
effects of HPV16 and HPV18 on the human breast cancer
cell lines, T-47D and MCF7, following transient transfection with the full length HPV virus. Normal breast and
fibroblast cell lines, MCF10A and Hs27, were used as noncancerous controls.
Results
HPV16 and HPV18 significantly inhibited proliferation
and adhesion of T-47D cells, although viability was not
affected. Differential effects on proliferation were observed in MCF7 cells; HPV16 inhibited proliferation,
while HPV18 stimulated proliferation. No measurable
effects in adhesion or viability in MCF7 cells were observed. The phenotypic changes in T-47D and MCF7 cells
were associated with changes in mRNA expression of
caspase-2,-3 and -8, but not p53 or GAPDH. No measurable changes in proliferation or viability were observed
following HPV transfection in the normal human breast
cell line, MCF10A, or the normal human fibroblast cell
line, Hs27, although adhesion was differentially affected.
Conclusions
Although HPV is a primary cause of virtually all cervical cancers, it is found as a concomitant infection in many
other tumors. While HPV may initiate carcinogenesis in

these tumors, recent studies suggest HPV may also modulate the progression or malignancy process in already transformed cancers. Determining what effects HPV has on
already transformed breast cancers may therefore become
an important step towards understanding the factors that
will lead to more effective treatment options for a significant proportion of breast cancer patients.
Keywords: Breast cancer; Human papillomavirus
Introduction
Viruses, including Epstein-Barr, Cytomegalovirus, and Herpes simplex virus, have been implicated in the etiology of human breast cancers (Lawson et al., 2001; Lawson et al., 2006;
Tsai et al., 2007). Recent evidence now suggests that high-risk
human papillomavirus (HPV) strains HPV16 and HPV18, primarily associated with cervical cancers, are also present in as
many as half of breast carcinoma biopsies (Kan et al., 2005; de
Villiers et al., 2005). HPV has been implicated as the causative
agent in many intraepithelial neoplasias and invasive squamous
cell carcinomas, with the HPV16 and HPV18 strains most frequently observed, with HPV16 the most prevalent among noncervical cancers, such as oral and breast cancers (Herrero et al.,
2003; Munoz et al., 2003; Kan et al., 2005; Smith et al., 2007).
Infection with high-risk HPV plays a central role in the carcinogenesis and etiology of nearly all cases of cervical cancer,
therefore HPV may also function to transform oral and breast
tissue (Walboomers et al., 1999; Kreimer et al., 2005; Syrjanen
2005). However, evidence from oral biopsies reveals a comparatively low presence of HPV in pre-malignant oral lesions
(10%), suggesting a role other than transformation (Kreimer et
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al., 2005; Syrjanen, 2005). More recent evidence demonstrates
HEPES, and 1.0 mM sodium pyruvate. MCF7 cells were mainthat high-risk HPV strains most commonly associated with these
tained in Minimum Essential Medium (MEM) with 2.00 mM
HPV-positive oral cancers significantly alters in vitro growth
L-Glutamine with Earle’s Balanced Salts. MCF10A breast con(Kingsley et al., 2006; Reddout et al., 2007). When combined
trol cells were maintained in DME/F-12 with 2.50 mM Lwith evidence that HPV is present only in a subset of oral canGlutamine and 15 mM HEPES buffer with 0.5 mg/ml hydrocers, these data imply that HPV infection may contribute to the
cortisone, 10 µg/mL EGF, 5 mg/ml insulin and 100 ng/ml cholmalignancy process in existing or developing cancers, rather
era toxin. Media for all cell lines were supplemented with 10%
than acting as a primary factor for inducing carcinogenesis
fetal bovine serum (FBS), and with 1% Penicillin (10,000 units/
(Gillison et al., 2000; van Houten et al., 2001).
mL)-Streptomycin (10,000 µg/ml) solution (HyClone), except
GH354 which was supplemented with 20% FBS and 1% PeniThe recent detection of HPV in a subset of breast cancers
cillin-Streptomycin. Cell cultures were maintained in 75 cm2
raises the question of whether, in addition to a role in carcinoBD Falcon tissue-culture treated flasks (Bedford, MA) at 37°C
genesis, HPV may also preferentially infect already developing
and 5% CO2 in humidified chambers.
tumors and subsequently mediate their growth (Kan et al., 2005;
de Villiers et al., 2005). New evidence to determine the specific
HPV screening
role of HPV in breast carcinogenesis suggests HPV may be inTo determine if these cell lines already harbor HPV, DNA
volved in the transformation process in a majority of the cases
was isolated from 1.5 x 107 cells from each cell line using the
examined (Khan et al., 2008). However, these data further sugGenomicPrep DNA isolation kit (Amersham Biosciences:
gest that in a significant subset of cases, other factors were likely
Buckinghamshire, UK), using the procedure recommended by
responsible for initiation of carcinogenesis and that HPV may
the manufacturer. To confirm the absence of HPV DNA in each
have preferentially infected these tumors, but not the surroundcell line prior to transfection and presence of HPV DNA in each
ing tissue. Based upon this information, this study was designed
cell line post-transfection, PCR was performed with the Fisher
to understand what effects HPV may have on already existing
exACTGene complete PCR kit (Fisher Scientific: Fair Lawn,
breast cancer cells.
NJ) and a Mastercycler gradient thermocycler (Eppendorf: HamResearchers hypothesize that several of the same risk factors
burg, Germany) using the following primers synthesized by
for developing cancer may also enhance the risk for acquiring
SeqWright (Houston, TX):
HPV infection. The main risk factors associated with breast canHPV18 forward primer, ATGGCGCGCTTTGAGGATCC;
cer include family history of disease, levels of hormones such
HPV18 reverse primer, GCATGCGGTATACTGTCTCT;
as estrogen and progesterone, as well as cigarette smoking and
HPV16 forward primer, ATGTTTCAGGACCCACAGGA;
alcohol consumption (Dean, 2008; Mahoney et al., 2008). These
HPV16 reverse primer, CCTCACGTCGCAGTAACTGT.
risk factors are not exclusive to breast cancer risk and may also
be strongly linked with HPV infection.
One µg of template DNA was used for each reaction. The
initial denaturation step ran for 1 minute at 94°C. Thirty amInterestingly, one recent study found that two HPV genes, E6
plification cycles were run, consisting of 30 second denaturand E7, were sufficient to induce changes to metastatic phenoation at 94°C, 60 seconds of annealing at 58°C, and 6.5 minutes
types in MCF7 and BT20 breast cancer cells, in vitro and in
of extension at 68°C. Final extension was run for 5 minutes at
vivo (Yasmeen et al., 2007a; Yasmeen et al., 2007b). To date,
68°C. Reaction products were separated by gel electrophoresis
no studies have yet examined the effects of the full-length HPV16
using Reliant 4% NuSieve® 3:1 Plus Agarose gels (Lonza:
or HPV18 virus on the proliferative phenotype of established
Rockland, ME). Bands were visualized by UV illumination of
breast cancers. This study is among the first to provide direct
ethidium-bromide-stained gels and captured using a Kodak Gel
evidence that elucidates the ability of HPV infection to alter the
Logic 100 Imaging System and 1D Image Analysis Software
proliferative phenotype of breast cancers in vitro.
(Eastman Kodak: Rochester, NY).

Materials and Methods
Cell culture

Transfection

MCF7 (HTB-22), T-47D (HTB-133), MCF10A (CRL-10317)
The human breast cancer cell lines used in this study, MCF7
and Hs27 (CRL-1634) cells were transfected with HPV16 and
(HTB-22) and T-47D (HTB-133), as well as the non-tumoriHPV18. Briefly, cells were seeded in 25cm2 BD Falcon tissuegenic epithelial breast cell line MCF10A (CRL-10317) and norculture treated flasks in appropriate media (as described) and
mal human fibroblast cell line Hs27 (CRL-1634), were obtained
allowed to achieve 70% confluence. Cells were then transiently
from American Type Culture Collection (ATCC: Manassas, VA).
transfected by adding 1 µg/ml of full-length HPV type 16, cloned
In addition, CaSki (CRL-1550: epidermoid carcinoma, cervix)
into the pBluescript SK-vector (ATCC #45113) or HPV type
and GH354 (CRL-13003: human cervical adenocarcinoma) were
18, cloned into the pBR322 vector (ATCC #45152). The transalso obtained from ATCC as HPV16 and HPV18 positive confections were performed using the Stratagene Mammalian Transtrols, respectively. Hs27 fibroblast control and GH354 cervical
fection Kit (La Jolla, CA) according to the manufacturer’s recadenocarcinoma cells were maintained in Dulbecco’s Modified
ommended protocol for CaPO4 transfection. Mock transfectants
Eagle’s Medium (DMEM) with 4 mM L-Glutamine, adjusted
(mTF) of these four cell lines were also established by performto contain 3.7 g/L sodium bicarbonate and 4.5 g/L glucose, from
ing the same transfection protocol, but without using virus
Hyclone (Logan, UT). T-47D and CaSki cells were maintained
(empty vector).
in RPMI-1640 medium with 2mM L-Glutamine, adjusted to conTo test the effectiveness of the transient transfections, RNA
tain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM
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was isolated from 1.5 x 10 cells of each of the experimental
and control cell lines, using ABgene Total RNA Isolation Reagent (Epsom, Surrey, UK) and the procedure recommended
by the manufacturer. To quantify the expression of HPV mRNA,
RT-PCR was performed on total RNA using the ABgene Reverse-iT One-Step RT-PCR Kit (ReadyMix Version) and a
Mastercycler gradient thermocycler (Eppendorf: Hamburg,
Germany) using the HPV18 and HPV16 primers synthesized
by SeqWright (Houston, TX).
One µg of template (total) RNA was used for each reaction.
The reverse transcription step ran for 30 minutes at 47°C, followed by denaturation for 2 minutes at 94°C. Thirty-five amplification cycles were run, consisting of 20 second denaturation
at 94°C, 30 seconds of annealing at 58°C, and 6.5 minutes of
extension at 72°C. Final extension was run for 5 minutes at 72°C.
Reaction products were separated by gel electrophoresis using
Reliant 4% NuSieve® 3:1 Plus Agarose gels (Lonza: Rockland,
ME). Bands were visualized by UV illumination of ethidiumbromide-stained gels and captured using a Kodak Gel Logic
100 Imaging System and 1D Image Analysis Software (Eastman
Kodak: Rochester, NY). Quantitation of RT-PCR band densitometry and relative mRNA expression levels was performed using Adobe Photoshop (San Jose, CA) imaging software, Image
Analysis tools.
Proliferation
Proliferation assays were performed with MCF7, T-47D,
MCF10A, and Hs27 cells with the appropriate complete media
in Corning Costar 96-well assay plates (Corning, NY), using
HPV16 or HPV18 transfected cells, mock-transfected cells, and
non-transfected controls. Cells were seeded at a concentration
of 1.2 x 104 cells per well and proliferation was measured over
three days at four time points (day 0 - day 3), as previously
described (Kingsley et al., 2006; Reddout et al., 2007). Cultured cells were fixed at each time point, 0 hours (day 0), 24
hours (day 1), 48 hours (day 2), and 72 hours (day 3), using 50
µl of 10% buffered formalin and subsequently stained with crystal violet 1% aqueous solution (Fisher Scientific: Fair Lawn,
NJ). Relative absorbance was then measured at 630 nm using a
Bio-Tek ELx808 microplate reader (Winooski, VT) and data
were analyzed and graphed using Microsoft Excel (Redmond,
WA) and SPSS (Chicago, IL). Three separate, independent replications of each experiment were performed.
Adhesion

- Open Access

JCST/Vol.1 Issue 2
tific: Fair Lawn, NJ). Relative absorbance was then measured
at 630 nm using a Bio-Tek ELx808 microplate reader (Winooski,
VT) and data were analyzed and graphed using Microsoft Excel (Redmond, WA). Three separate, independent replications
of each assay were performed.
Viability
Prior to plating cells for adhesion and proliferation assays,
aliquots of trypsinized cells were stained using Trypan Blue
(Sigma: St. Louis, MO), and live cells were enumerated by counting the number of Trypan-blue negative cells using a VWR Scientific Counting Chamber (Plainfield, NJ) and a Zeiss Axiovert
40 inverted microscope (Gottingen, Germany). At each time
point (day 0-3), several wells were processed using the Trypan
stain, and live cells were enumerated using this procedure
(Felsher et al., 2000; Kingsley et al., 2002).
RT-PCR
RNA was isolated from 1.5 x 107 cells of each of the experimental and control cell lines, using ABgene Total RNA Isolation Reagent (Epsom, Surrey, UK) and the procedure recommended by the manufacturer three days after transfection. RTPCR was performed on total RNA using the ABgene ReverseiT One-Step RT-PCR Kit (ReadyMix Version) and a
Mastercycler gradient thermocycler (Eppendorf: Hamburg,
Germany), as described above. The following primers for p53
(Vakifahmetoglu et al., 2006), caspase-2 and caspase-3 (Kugu
et al., 1998), caspase-8 (Ruiz-Ruiz et al., 2004), and glyceraldehyde-3- phosphate dehydrogenase (GAPDH) (Wolter et al.,
2003), synthesized by SeqWright (Houston, TX), were used:
p53 forward primer, ACCAGGGCAGCTACGGTTTC;
p53 reverse primer, CCTGGGCATCCTTGAGTTCC;
caspase-2 forward primer, TGGCATATAGGTTGCAGTCTC
GG;
caspase-2 reverse primer, TGTTCTGTAGGCTTGGGCA
GTTG;
caspase-3 forward primer, ACATGGAAGCGAATCAATG
GACTC;
caspase-3 reverse primer, AAGGACTCAAATTCTGTTG
CCACC;
caspase-8 forward primer, GATATTGGGGAACAACTGGAC;
caspase-8 reverse primer, CATGTCATCATCCAGTTTGCA;
GAPDH forward primer, ATCTTCCAGGAGCGAGATCC;
GAPDH reverse primer, ACCACTGACACGTTGGCAGT;

Bands were visualized by UV illumination of ethidium-broAdhesion assays were performed at a concentration of 1.2 x
5
6
mide-stained
gels and captured using a Kodak Gel Logic 100
10 cells per well (100 µl of 1.2 x 10 cells/ml solution susImaging
System
and 1D Image Analysis Software (Eastman
pended in serum-free DMEM, MEM, DME:F-12 or RPMI with
Kodak:
Rochester,
NY). Quantitation of RT-PCR band densino additives) in uncoated Corning Costar 96-well assay plates
tometry
was
performed
using Adobe Photoshop (San Jose, CA)
(Corning, NY) as previously described (Plopper et al., 1995;
imaging
software,
Image
Analysis tools.
Wagner et al., 2002; Reddout et al., 2007). Cells were allowed
to attach for 30 minutes at 37°C with one modification to the
Statistics
standard adhesion assay. The modified adhesion assays used in
The differences between treatments were measured using a t
this study eliminated the plate suspension step, in which nondistribution
(α=0.05). All samples were analyzed using twoadherent cells are generally removed by suspending the plate
tailed
t-tests,
as departure from normality can make more of a
upside-down in a rotating tank of PBS, which greatly enhances
difference
in
a
one-tailed than in a two-tailed t-test. As long as
the sensitivity of this assay, as previously described (Kingsley
the
sample
size
is even moderate (>20 for each group), quite
et al., 2006). Following the incubation period, the cells were
severe
departures
from normality make little practical differfixed using 50 µl of 10% buffered formalin and subsequently
ence
in
the
conclusions
reached from these analyses (Hays,
stained with crystal violet 1% aqueous solution (Fisher ScienJ Cancer Sci Ther
Volume 1(2) : 062-071 (2009) - 064
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1994). However, analyses involving multiple two sample t-tests
Hs27-HPV18TF
have a higher probability of Type I error, leading to false rejecMCF10A-HPV18TF
tion of the null hypothesis, H0 (Hays, 1994). To confirm the
MCF7-HPV18TF
effects observed from these experiments and minimize the posT-47D-HPV18TF
sibility of Type I error, further analysis of the data was faciliGH354
tated with ANOVA using SPSS (Chicago, IL) to more accuHs27-HPV16TF
rately assess relationships and statistical significance among and
MCF10A-HPV16TF
between groups.
MCF7-HPV16TF
T-47D-HPV16TF
CaSki

Results
HPV screening

0

To confirm that each cell line did not already harbor HPV,
DNA was isolated from cultured cells and PCR performed using primers specific for HPV16 and HPV18. In addition, two
HPV-positive cervical cancer cell lines, CaSki (HPV16) and
GH354 (HPV18), were included as positive controls (Figure
1). These results demonstrated that T-47D, MCF7, MCF10A,
and Hs27 were not found to contain endogenous HPV, while
confirming that CaSki and GH354 harbor HPV16 and HPV18,
respectively. Furthermore, the presence of HPV DNA was not
observed in mock transfectants, but could be verified post-transfection.
Transfection

T47D:HPVTF

T-47D

GH354

CaSki

(-) control

A

(+) control

Effectiveness of the transient transfections and expression of
HPV mRNA was assessed by performing RT-PCR on total RNA
isolated from each cell line post-transfection and on the cell
lines known to harbor endogenous HPV (CaSki, GH354). These
results demonstrate that each HPV16-transfectants (Hs27HPV16 and MCF10A-HPV16), expressed roughly equivalent

HPV16

-188 bp
-124 bp

HPV18

-124 bp

Hs27: HPVTF

Hs27

MCF10:HPVTF

MCF1:10A

MCF7:mTF

MCF7

B

MCF7:HPTF

-188 bp

-188 bp

HPV16

-124 bp

HPV18

-124 bp

-188 bp

Figure 1: HPV was detectable in experimental cell lines only after transfection.
(A) PCR from total DNA demonstrated that CaSki and GH354 contain HPV16
and HPV18 specific sequences, respectively. PCR from total DNA of experimental cell lines confirms T-47D (A), MCF7, MCF10A and Hs27 (B) do not
harbor these HPV-specific sequences. Following transfection with the fulllength HPV genome, each cell was found to contain HPV16 or HPV18 sequences, but not among mock transfectants (empty vector), such as T-47D mTF
(A) or MCF7 mTF (B).

20

40

60

80

100

Relative HPV mRNA expression (arb. units)

Figure 2: HPV expression in vitro was comparable among transfectants.
RT-PCR confirmed HPV expression in all four cell lines (T-47D, MCF7,
MCF10A and Hs27) following HPV16 or HPV18 transfection. Scanning densitometry measurement of relative endpoint RT-PCR band intensities from all
HPV18-transfectants were comparable, although lower than endogenous HPV
expression from GH354 cells (top). HPV mRNA expression in T-47D and MCF7
HPV16-transfectants were roughly equivalent to endogenous expression from
CaSki cells, and slightly higher than expression in normal cells, Hs27 and
MCF10A (bottom).

amounts of virus mRNA, while MCF7-HPV16 andT-47DHPV16 had slightly higher HPV mRNA expression profiles
(Figure 2). Comparison with CaSki HPV16-specific mRNA reveals that endogenous HPV expression was approximately
equivalent to the transfectants, although slightly lower among
the normal cell lines. HPV18-transfectants (Hs27-HPV18,
MCF10A-HPV18, MCF7-HPV18, and T-47D-HPV18) expressed roughly equivalent amounts of virus mRNA, while comparison with GH354 HPV18-specific mRNA revealed that endogenous HPV mRNA expression was slightly higher than that
of HPV18 transfectants.
Previous studies with oral cancers revealed that transfection
with the full-length HPV16 and HPV18 genome significantly
altered cellular proliferation, adhesion, and viability. To test the
hypothesis that HPV16 and HPV18 strains similarly alter the
phenotypes of breast cancer cells, in vitro assays were performed
following transfection with HPV16 and HPV18.
HPV inhibited proliferation and adhesion in T-47D cells
Transfection of T-47D cells with HPV16 resulted in lower
proliferation compared with non-transfected controls (-42%),
as did HPV18 (-39%) (p<0.01, n=216) (Figure 3A). Because
these analyses involved multiple two-sample t-tests and a higher
probability of Type I error, ANOVA was performed. This analysis
confirmed that both HPV16 and HPV18 inhibited cellular proliferation in T-47D cells. T-47D-HPV16 proliferation was not
significantly different from T-47D-HPV18 proliferation, however, they were both significantly different from the mock and
non-transfected controls.
Based upon the results of the proliferation assay, we sought
to determine if this response correlated with measurable alterations to cellular adherence or cellular viability. Baseline T47D adhesion (without HPV) was significantly reduced by both
HPV16 (-16%; n=72, p<0.01) and HPV18 (-15%; n=72, p<0.01)
(Figure 3B), although measurements of cell survival and viability revealed no significant differences between groups (Table
1).
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0.6
0.5
0.4

T-47D
T-47D-HPV16

0.3

T-47D-HPV18

0.2
0.1

A

d2

To contextualize the HPV-induced changes in the setting of
breast cancer phenotypes that were observed, the responses of
a non-cancerous cell line were also assayed using the normal
human breast cell line, MCF10A. These experiments found no
significant differences between transfected (HPV16 or HPV18)
and non-transfected cells (Figure 5A). Two-tailed t-tests and
ANOVA were used to confirm that no statistical significance
was evident between these groups.
Although HPV exhibited no significant effects on the growth
or proliferation of MCF10A cells, cellular adhesion and viabil-

0
d1

JCST/Vol.1 Issue 2
HPV induced minor changes to adhesion in the normal
breast cell line, MCF10A

T-47D proliferation

d0

d3

Days in Culture

MCF7 proliferation assay

0.16
0.14

1.2

0.12

1

0.1

Relative absorbance (630 nm)

Relative absorbance (630 nm)
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0.08
0.06
0.04

0.8
MCF7

0.6

MCF7-HPV16
MCF7-HPV18

0.4

0.2

0.02

0
0
T 4 7 D -H P V 1 6
Treatment category

d0

A

d1

d2

d3

Days in Culture
0.2

Sum of
Squares
Between 2.160
Within
4.822
Total
6.982

C

T 4 7 D -H P V 1 8

T47D

HPV16
0.000000

ANOVA
df
Mean
F
Sig.
Square
2
1.080 47.70 .000
213 .023
215
two-tailed t-test (p value)
HPV18
0.000000

Figure 3: Proliferation and adhesion of T-47D cells was significantly inhibited by HPV16 or HPV18 in vitro.
HPV-transfected and control T-47D cells were plated in 96-well assay plates
with media containing 10% FBS and were allowed to proliferate for three days.
(A) HPV16 and HPV18 transfected cells exhibited reduced proliferation significantly (-42%, -39%, respectively; p<0.01, n=216). (B) T-47D adhesion was
significantly inhibited by HPV16 (-15.9%) and HPV18 (-15.1%), as measured
by modified 30-minute adhesion assays (p<0.05, n=72).

0.18
0.16
0.14

Relative absorbacne (630 nm)

B

T47 D

0.1
0.08
0.06
0.04
0.02

B

0
MC F 7

M C F 7 -H P V 1 6

C

M C F 7 -H P V 1 8

Treatment category

Sum of
Squares
Between .691
6.588
Within
7.278
Total

HPV induced differential changes in MCF7 cell proliferation
Transfection of the MCF7 cells with HPV16 reduced proliferation (-9.9%), while HPV18 stimulated proliferation (+10.4%)
in comparison to non-transfected controls (p<0.05, n=216) (Figure 4A). Two-tailed t-tests and one-way ANOVA confirmed this
differential response was statistically significant between both
experimental groups and the controls.

0.12

MCF7

HPV16
0.017056

ANOVA
F
Mean
df
Square
.345 11.166
2
213 .031
215

Sig.
.000

two-tailed t-test (p value)
HPV18
0.024407

Figure 4: Proliferation of MCF7 cells, but not adhesion, was differentially influenced by HPV16 or HPV18 in vitro.

HPV-transfected and control MCF7 cells were plated in 96-well assay plates
In contrast to the differential response in proliferation obwith media containing 10% FBS and were allowed to proliferate for three days.
served following HPV transfection, no significant changes to
(A) HPV16-transfected cell proliferation was significantly inhibited (-9.9%),
adhesion were observed in MCF7 cells (Figure 4B). Analysis
while HPV18-transfected cell proliferation was significantly enhanced (+10.4%)
of cellular viability revealed only minor, non-significant reduc(p<0.05, n=216). (B) MCF7 cell adhesion was not significantly affected by
tions in cellular viability between the HPV-transfected MCF7
HPV16 (-0.6%) or HPV18 (+6.8%), as measured by modified 30-minute adhesion assays (p>0.05, n=72).
cells and controls (Table 1).
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+2.7%
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0.14

Table 1: Cell viability in control and HPV-transfected cells.

ity assays were also performed to assess if other behaviors were
affected. Unlike growth and proliferation, cellular adhesion of
MCF10A cells was significantly altered by HPV16 (+9.5%,
p<0.01, n=144) and HPV18 (+11.06%, p<0.01, n=144) compared with non-transfected controls (Figure 5B), although no
differences in viability were observed (Table 1).
HPV induced minor changes to adhesion in the normal fibroblast cell line, Hs27
To further compare and contrast the HPV-induced phenotypic
that were observed between the cancerous and non-cancerous
cells tested, the responses of another non-cancerous cell line
were also assayed using the normal human fibroblast cell line,
Hs27. The results revealed no significant differences between
the proliferation of Hs27 cells transfected with HPV16 or
HPV18 and non-transfected Hs27 controls (p>0.05, n=72) (Figure 6A). Two-tailed t-tests confirmed no statistical differences
in proliferation were found between the groups (Hs27-HPV16,
p>.05; Hs27-HPV18, p>.05). ANOVA confirmed there were no
significant differences between or within the experimental and
control groups.
In addition to testing the effects of HPV16 and HPV18 on the
proliferation of Hs27 cells, cellular adhesion and viability were
assessed. Adhesion of the non-transfected Hs27 cells was significantly inhibited by HPV16 (-19.25%, p>0.05, n=72) but not
by HPV18 (+13.12%, p>0.05, n=72) (Figure 6B). In addition,
no significant changes in viability were observed with Hs27HPV16 or HS27-HPV18 transfectants (Table 1).
RT-PCR
Researchers have established that the principle tumorigenic
activity of HPV early genes, including E6, may be the targeting, subsequent degradation, and down regulation of the tumor
suppressor p53 (Scheffner et al., 1990; Sun et al., 2008). Because damaged genes and other molecular pathways in cancerous cells may involve deactivation of key tumor suppressors,
such as p53, total RNA was extracted from cells and relative
endpoint (RE) RT-PCR was performed to assess p53 expression in these cells (Figure 7). Wild type p53 expression was
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F
Mean
df
Square
.080 2.799
2
213 .032
215

Sig.
.190

two-tailed t-test (p value)
HPV18
0.197608

Figure 5: HPV16 and HPV18 did not significantly alter MCF10A phenotypes in vitro.
HPV-transfected and control MCF10A cells were plated in 96-well assay plates
with media containing 10% FBS and were allowed to proliferate for three days.
(A) HPV16- and HPV18-transfected cell proliferation was similar and not significantly different from control cells (p>0.05, n=216). (B) MCF10A cell adhesion was significantly enhanced by HPV16 (+9.5%) and HPV18 (+11.06%), as
measured by modified 30-minute adhesion assays (p<0.05, n=72).

observed in both T-47D (Figure 7A) and MCF7 (Figure 7B)
breast cancer cell lines, confirming earlier observations (Ho et
al., 2005; Parssinen et al., 2008). The expression levels of p53
mRNA, however, were not significantly altered by HPV16 or
HPV18 transfection in either cell line over the time course of
these assays (Day 3 shown; Figure 7A, B), as was recently demonstrated in some oral cancer cell lines transfected with HPV
(Chatelain et al., 2008).
Recently, other studies have suggested that HPV viral genome
amplification may also be dependent upon caspase-mediated
cleavage within the infected cells, which in turn may influence
differentiation and cellular replication rates (Moody et al., 2007;
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Persistent infection with high-risk, oncogenic HPV strains has
been firmly established as the primary cause of virtually all cases
of cervical cancer (Walboomers et al., 1999; Castellsague, 2008).
In contrast, ample evidence now confirms that HPV is present
in a subset of oral cancers and more recently, in breast cancers
that may be unrelated to carcinogenesis (Kan et al., 2005; de
Villiers et al., 2005; Kreimer et al., 2005; Syrjanen, 2005). Some
evidence now suggests that HPV infection in these tissues may
contribute to, rather than directly cause, the malignancy or transformation process.
For example, a recent study explored the potential roles of
HPV in breast cancer patients. This study revealed that approximately two-thirds of normal epithelial tissue samples taken
from sites adjacent to HPV16-expressing breast carcinomas also
contained HPV16 DNA (Khan et al., 2008), suggesting that HPV
may have induced transformation in the larger subset of these
A

Figure 6: HPV16 and HPV18 did not significantly alter Hs27 phenotypes
in vitro.
HPV-transfected and control Hs27 cells were plated in 96-well assay plates
with media containing 10% FBS and were allowed to proliferate for three days.
(A) HPV16- and HPV18-transfected cell proliferation was similar and not significantly different from control cells (p>0.05, n=216). (B) Hs27 cell adhesion
was significantly inhibited by HPV16 (-19.25%), but not by HPV18 (-13.12%),
as measured by modified 30-minute adhesion assays (p>0.05, n=72).

Coelho et al., 2008). (RE) RT-PCR was performed to determine if the effects of HPV16 and HPV18 transfection on these
cells correlated with differential expression of specific members of the caspase family (Figure 7). In sharp contrast to p53
expression, marked increases in the expression of caspase-2, 3, and-8 mRNA were observed in T-47D cells following HPV
transfection (Figure 7A). MCF7 cells, however, exhibited differential responses to HPV transfection (Figure 7B), with HPV16
reducing and HPV18 stimulating caspase-2 mRNA expression
levels. Interestingly, caspase-3 mRNA expression was undetectable in this cell line and no significant changes in caspase-8
mRNA were observed in either cell line. No changes to mRNA
expression levels were observed in Hs27 or MCF10A cells (data
not shown).
To quantify the relative changes in mRNA expression levels
from the experimental and control groups, scanning densitometry was performed. Specifically, HPV16 increased expression
of the apoptosis initiators caspase-2 (+28.55%) and caspase-3
(+47.55%), as well as the apoptosis-effector caspase-8

B
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0
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(+32.02%) in T-47D cells; HPV18 also increased expression of
caspase-2 (+26.37%), caspase-3 (+53.87%) and caspase-8
(+50.63%), revealing that caspase mRNA expression levels were
significantly altered by HPV16 or HPV18, but not levels of
p53 or GAPDH mRNA. The differential response of MCF7 cells,
however, revealed that HPV16 reduced expression of caspase2 (-14.5%), while HPV18 increased caspase-2 mRNA expression (+18.34%).

T47D: HPV16TF

A

0.6

JCST/Vol.1 Issue 2

T47D: control

Relative absorbance (630 nm)

0.7

- Open Access

Figure 7: T-47D and MCF7 mRNA analysis.
RT-PCR was performed on total RNA extracted from 107 T-47D (A) and MCF7
(B) cells at 24 and 48 hours (data not shown), and 72 hours. Relative endpoint
(RE) RT-PCR revealed that p53 and GAPDH expression levels remained relatively constant pre- and post-transfection in both cell lines. HPV16 and HPV18
significantly enhanced expression of caspase-2, -3 and -8 in T-47D cells (A),
while no significant changes were noted in MCF7 cells (B). Note: caspase-3
mRNA was undetectable in MCF7 cells at all time points. Scanning densitometry was performed from RE-RT-PCR results, revealing HPV16 increased expression of caspase-2 (+28.55%), caspase-3 (+47.55%), and caspase-8
(+32.02%) in T-47D cells; MCF7 cells exhibited a differential response, with
HPV16 reducing expression of caspase-2 (-14.5%) and HPV18 increasing
caspase-2 mRNA expression (+18.34%); no significant measurable differences
in caspase-8 mRNA were evident.
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breast cancer patients. However, these data also provide strong
lation in some cells without mRNA down regulation (Shin et
evidence that HPV was not involved in the etiology of the smaller
al., 2006; Sun et al., 2008). Data indicating that wild-type p53
subset, which did not contain any discernable evidence of a loexpression was not reduced by HPV transfection in these breast
calized HPV infection. Although many studies suggest that specancers might suggest that HPV in these cell lines may instead
cific oncogenic HPV strains may be present in up to half of
utilize other mechanisms, such as phosphorylation-mediated inbreast cancer biopsies, few studies to date have investigated the
activation of p53. Future studies are now planned to explore
possibility that HPV infection may, in fact, mediate specific phethese potential mechanisms.
notypes associated with the malignancy process (Kan et al.,
Although deregulation or deactivation of p53 and other tu2005; de Villiers et al., 2005). This study is among the first to
mor suppressors may be critical to the mechanisms of the HPV
provide direct evidence that HPV is capable of modulating the
life cycle, other work has demonstrated that HPV viral genome
proliferative phenotypes of existing breast cancers.
amplification may also be dependent upon caspase-mediated
Based upon results from other studies demonstrating HPV
functions within infected cells (Moody et al., 2007; Coelho et
mediates the proliferative phenotypes of oral cancers (Kingsley
al., 2008). These studies reveal that the productive viral life
et al., 2006; Reddout et al., 2007), the current study investicycle of HPV is significantly enhanced by caspase-mediated
gated whether high-risk HPV16 and HPV18 strains induce sigcleavage that may, in fact, be integral to the HPV viral life cycle.
nificant and measurable changes in breast cancer phenotypes,
Aside from their incidental involvement in the HPV life cycle,
including proliferation. The results indicated that either HPV
caspases function primarily as potent activators of cellular
strain is sufficient to alter growth rates in both of the breast
apoptosis and are known to inhibit cellular proliferation. Caspase
cancer cell lines examined, but not normal cells. Although preup-regulation and proliferation inhibition have also been obvious evidence has demonstrated that HPV16 and HPV18 were
served in previous work using cervical cancer cells (Moody et
sufficient to immortalize a normal human mammary epithelial
al., 2007; Coelho et al., 2008; Singh and Singh, 2008). Intrigucell line, these studies were not designed to explore the possiingly, the anti-cancer mechanism of Taxol (Paclitaxel), a potent
bility that HPV might have differential effects in already transtreatment for ovarian, lung and breast cancers, was recently
formed cells (Band et al. 1990). Moreover, previous studies of
determined to involve activation of members of the caspase famHPV-mediated effects on normal cell lines, including human
ily, more specifically caspase-8 (Lee et al., 2005).
foreskin keratinocytes and normal breast tissues, were designed
Despite the growing evidence that high-risk HPV strains are
to assay HPV-induced immortalization, or escape from senespresent in many breast tumors, few studies have examined the
cence, rather than the relative proliferation or turnover rates of
ability of HPV to modulate cellular phenotypes in these canthese cells in culture (Band et al., 1990; Hawley-Nelson et al.,
cers. Although epidemiologic studies suggest other risk factors,
1999). Finally, new evidence is emerging which suggests HPV
such as genetic predisposition and tobacco or alcohol use, are
infection in some oral cancers may actually increase patient
likely responsible for breast oncogenesis, new evidence sugsurvival under certain conditions, suggesting a clinical correlagests concomitant HPV infection may significantly alter tumor
tion with these differential proliferative responses (Fischer et
growth. This study provides direct evidence that HPV16 and
al., 2009; Jung et al., 2009).
HPV18 can modulate the proliferative phenotypes in existing
The experimental design of this study was employed specifibreast cancer cell lines, although more research is needed to
cally to reveal the presence of differential responses, not only
understand the complex inter-relationships between the observed
between the cell lines, but also between different HPV strains
effects of HPV infection and specific intrinsic or cytogenetic
within the same cell line. These data now suggest complex indifferences that control this phenomenon. Determining the efter-relationships between the effects of HPV infection and infects of HPV on already transformed breast cancers is thus an
trinsic cellular or cytogenetic differences. Moreover, these reimportant step towards understanding the factors that will ultisults bear some resemblance to previous work from this laboramately lead to more accurate prognosis and more effective treattory that demonstrated these high risk HPV strains do not elicit
ment options for breast cancer patients with concomitant HPV
equivalent responses among all oral cancer cell lines tested, and
infections.
that different HPV strains may inhibit or increase cell proliferaAcknowledgements
tion within the same cell line (Reddout et al., 2007).
This research was supported by a Research Development
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instance, HPV viral replication proteins influence cellular prowith
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liferation in most cervical cancers by inactivating degrading,
and subsequently down regulating tumor suppressor proteins,
such as p53 (Scheffner et al., 1990; Werness et al., 1990). However, in this study, HPV transfection did not significantly alter
p53 expression in either breast cancer cell line, which may seem
at odds with the evidence from cervical cancers.

References

Recent work now confirms that many viruses have evolved
alternative mechanisms to inhibit p53 function. For example,
p53 deactivation may occur via site-specific serine phosphory-

2. Castellsague X (2008) Natural history and epidemiology of HPV infection
and cervical cancer. Gynecol Oncol 110: S4-7. » CrossRef » PubMed » Google

1. Band V, Zajchowski D, Kulesa V, Sager R (1990) Human papilloma virus
DNAs immortalize normal human mammary epithelial cells and reduce
their growth factor requirements. Proc Natl Acad Sci USA 87: 463-467. »
CrossRef » PubMed » Google Scholar

Scholar

J Cancer Sci Ther

Volume 1(2) : 062-071 (2009) - 069
ISSN:1948-5956 JCST, an open access journal

Journal of Cancer Science & Therapy
www.omicsonline.org
3. Chatelain K, Phippen S, McCabe J, Teeters CA, O’Malley S, et al. (2008)
Cranberry and grape seed extracts inhibit the proliferative phenotype of
oral squamous cell carcinomas. Evid Based Complement Alternat Med
[Epub ahead of print]. » CrossRef » PubMed » Google Scholar
4. Coelho RA, Focchi GR, Nogueira-de-Souza NC, Sartori MG, Silva ID, et
al. (2008) Prognostic markers of low-grade squamous intraepithelial lesions:
the role of topoisomerase II alpha and active caspase-3. Eur J Gynaecol
Oncol 29: 499-501. » CrossRef » PubMed » Google Scholar

- Open Access

JCST/Vol.1 Issue 2
baboon ovary. Cell Death Differ 5: 67-76. » CrossRef

» PubMed » Google Scholar

21. Lawson JS, Tran D, Rawlinson WD (2001) From Bittner to Barr: a viral,
diet and hormone breast cancer aetiology hypothesis. Breast Cancer Res 3:
81-85. » CrossRef » PubMed » Google Scholar
22. Lawson JS, Gunzburg WH, Whitaker NJ (2006) Viruses and human breast
cancer. Future Microbiol 1: 33-51. » CrossRef » PubMed » Google Scholar

5. Dean A (2008) Primary breast cancer: risk factors, diagnosis and management. Nurs Stand 22: 47-55. » CrossRef » PubMed » Google Scholar

23. Lee KH, Yim EK, Kim CJ, Namkoong SE, Um SJ, et al. (2005) Proteomic
analysis of anti-cancer effects by paclitaxel treatment in cervical cancer
cells. Gynecol Oncol 98: 45-53. » CrossRef » PubMed » Google Scholar

6. de Villiers EM, Sandstrom RE, Hausen ZH, Buck CE (2005) Presence of
papillomavirus sequences in condylomatous lesions of the mammillae and
in invasive carcinoma of the breast. Breast Cancer Res 7: R1-R11. » CrossRef

24. Mahoney MC, Bevers T, Linos E, Willett WC (2008) Opportunities and
strategies for breast cancer prevention through risk reduction. CA Cancer J
Clin 58: 347-71. » CrossRef » PubMed » Google Scholar

» PubMed » Google Scholar

7. Felsher DW, Zetterberg A, Zhu J, Tisty T, Bishop JM (2000) Overexpression
of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl
Acad Sci USA 97: 10544-10548. » CrossRef » PubMed » Google Scholar

25. Moody CA, Fradet-Tucotte A, Archambault J, Laimins LA (2007) Human
papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci USA 104: 2954119546.
» CrossRef » PubMed » Google Scholar

8. Fischer CA, Zlobec I, Green E, Probst S, Storck C, et al. (2009) Is the
improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality. Int J Cancer [Epub ahead of
» CrossRef » PubMed » Google Scholar
print].

26. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsaque X, et al. (2003)
Epidemiologic classification of human papillomavirus types associated with
cervical cancer. N Engl J Med 348: 518-527. » CrossRef » PubMed » Google

9. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. (2000)
Evidence for a causal association between human papillomavirus and a
subset of head and neck cancers. J Natl Cancer Inst 92: 675-677. » CrossRef

27. Parssinen J, Alarmo EL, Karhu R, Kallioniemi A (2008) PPM1D silencing
by RNA interference inhibits proliferation and induces apoptosis in breast
cancer cell lines with wild-type p53. Cancer Genet Cytogenet 182: 33-39.

Scholar

» CrossRef » PubMed » Google Scholar

» PubMed » Google Scholar

10. Hawley-Nelson P, Vousden KH, Hubbert NL, Lowy DR, Schiller JT (1989)
HPV16 E6 and E7 proteins cooperate to immortalize human foreskin
keratinocytes. EMBO J 8: 3905-3910. » CrossRef » PubMed » Google Scholar

28. Plopper GE, McNamee HP, Bojanowski K, Ingber DE (1995) Convergence
of integrin and growth factor receptor signaling pathways within the focal
adhesion complex. Mol Biol Cell 6: 349-1365. » CrossRef » PubMed » Google
Scholar

11. Hays WL (1994) Inferences about population means. In: Statistics (5th edition). International Thomson Publishing 311-342. » CrossRef » PubMed » Google
Scholar

12. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, et al. (2003)
Human papillomavirus and oral cancer: The International Agency for Research on Cancer multicenter study. J Natl Cancer Inst 95: 1772-1783.
» CrossRef » PubMed » Google Scholar

13. Ho CY, Kim CF, Leung KN, Fung KP, Tse TF, et al. (2005) Differential
anti-tumor activity of coriolus versicolor (Yunzhi) extract through p53and/or Bcl-2-dependent apoptotic pathway in human breast cancer cells.
Cancer Biol Ther 4: 638-644. » CrossRef » PubMed » Google Scholar
14. Jung AC, Briolat J, Millon R, de Reynies A, Rickman D, et al. (2009)
Biological and clinical relevance of transcriptionnally active human
papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.
Int J Cancer [Epub ahead of print]. » CrossRef » PubMed » Google Scholar
15. Kan CY, Iacopetta BJ, Lawson JS, Whitaker NF (2005) Identification of
human papillomavirus DNA sequences in human breast cancer. Br J Cancer 93: 946-948. » CrossRef » PubMed » Google Scholar
16. Khan NA, Castillo A, Koriyama C, Kijima Y, Umekita Y, et al. (2008)
Human papillomavirus detected in female breast carcinomas in Japan. Br J
Cancer 99: 408-414. » CrossRef » PubMed » Google Scholar
17. Kingsley K, Huff JL, Rust WL, Carroll K, Martinez AM, et al. (2002) ERK
1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5. Biochem Biophys Res Commun 293:
1000-1006. » CrossRef » PubMed » Google Scholar
18. Kingsley K, Johnson D, O’Malley S (2006) Transfection of oral squamous
cell carcinoma with human papillomavirus-16 induces proliferative and
morphological changes in vitro. Cancer Cell Int 6: 14. » CrossRef » PubMed »
Google Scholar

19. Kreimer AR, Clifford GM, Boyle P, Franceschi S (20 05) Hu man
papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14: 467475. » CrossRef » PubMed » Google Scholar
20. Kugu K, Ratts VS, Piquette GN, Tilly KI, Tao XJ, et al. (1998) Analysis of
apoptosis and expression of bcl-2 gene family members in the human and

29. Reddout N, Christensen T, Bunnell A, Jensen D, Johnson D, et al. (2007)
High risk HPV types 18 and 16 are potent modulators of oral squamous
cell carcinoma phenotypes in vitro. Infect Agent Cancer 2: 21. » CrossRef »
PubMed » Google Scholar

30. Ruiz-Ruiz C, Ruiz de Almodovar C, Rodriguez A, Ortiz-Ferron G, Redondo
JM, et al. (2004) The up-regulation of human caspase-8 by interferongamma in breast tumor cells requires the induction and action of the
transcription factor interferon regulatory factor-1. J Biol Chem 279: 1971219720. » CrossRef » PubMed » Google Scholar
31. Scheffner M, Werness BA, Huibregtse JM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation
of p53. Cell 63: 1129-1136. » CrossRef » PubMed » Google Scholar
32. Shin YC, Nakamura H, Liang X, Feng P, Chang H, et al. (2006) Inhibition
of the ATM/p53 signal transduction pathway by Kaposi’s sarcomaassociated herpesvirus interferon regulatory factor I. J Virol 80: 2257-2266.
» CrossRef

» PubMed » Google Scholar

33. Singh M, Singh N (2008) Induction of apoptosis by hydrogen peroxide in
HPV 16 positive human cervical cancer cells: involvement of mitochondrial pathway. Mol Cell Biochem 310: 57-65. » CrossRef » PubMed » Google
Scholar

34. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, et al. (2007) Human
papillomavirus type distribution in invasive cervical cancer and high-grade
cervical lesions: a meta-analysis update. Int J Cancer 121: 621-632. » CrossRef
» PubMed » Google Scholar

35. Sun L, Zhang G, Li Z, Song T, Huang C, et al. (2008) In GFP with high risk
HPV-18E6 fusion protein expressed 293T and MCF-7 cells, the endogenous
wild-type p53 could be transiently phosphorylated at multiple sites. J Clin
Exp Clin Cancer Res 27: 35. » CrossRef » PubMed » Google Scholar
36. Syrjanen S (2005) Human papillomavirus (HPV) in head and neck cancer.
J Clin Virol 32: s59-66. » CrossRef » PubMed » Google Scholar
37. Tsai JH, Hsu CS, Tsai CH, Su JM, Liu YT, et al. (2007) Relationship between viral factors, axillary lymph node status and survival in breast cancer. J Cancer Res Clin Oncol 133: 13-21. » CrossRef » PubMed » Google Scholar
38. Vakifahmetoglu H, Olsson M, Orrenius S, Zhivotovsky B (2006) Func-

J Cancer Sci Ther

Volume 1(2) : 062-071 (2009) - 070
ISSN:1948-5956 JCST, an open access journal

Citation: Kingsley K, Zuckerman J, Davis M, Matteucci M, Knavel A, et al. (2009) Induction of Differential Growth in vitro by Highrisk Human Papillomavirus in Human Breast Cancer Cell Lines is Associated with Caspase Dysregulation. J Cancer Sci Ther 1: 062071. doi:10.4172/1948-5956.1000010
tional connection between p53 and caspase-2 is essential for apoptosis induced by DNA damage. Oncogene 25: 5683-5692. » CrossRef » PubMed »
Google Scholar

39. van Houten VM, Snijders PJ, van den Brekel MW, Kummer JA, Meijer CJ,
et al. (2001) Biological evidence that human papillomaviruses are etiologically involved in a subgroup of head and neck squamous cell carcinomas. Int J Cancer 93: 232-235. » CrossRef » PubMed » Google Scholar
40. Wagner JE, Huff JL, Rust WL, Kingsley K, Plopper GE (2002) Perillyl
alcohol inhibits breast cell migration without affecting cell adhesion. J
Biomed Biotechnol 2: 136-140. » CrossRef » PubMed » Google Scholar
41. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al.
(1999) Human papillomavirus is a necessary cause of invasive cervical
cancer worldwide. J Pathol 189: 12-19. » CrossRef » PubMed » Google Scholar

papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76-79.
» CrossRef » PubMed » Google Scholar

43. Wolter F, Turchanowa L, Stein J (2003) Resveratrol-induced modification
of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis 24: 469-474. » CrossRef » PubMed » Google Scholar
44. Yasmeen A, Bismar TA, Kandouz M, Foulkes WD, Desprez PY, et al. (2007)
E6/E7 of HPV type 16 promotes cell invasion and metastasis of human
breast cancer cells. Cell Cycle 6: 2038-2042. » CrossRef » PubMed » Google
Scholar

45. Yasmeen A, Bismar TA, Dekhil H, Ricciardi R, Kassab A, et al. (2007)
ErbB-2 receptor cooperates with E6/E7 oncoproteins of HPV type 16 in
breast tumorigenesis. Cell Cycle 6: 2939-2943. » CrossRef » PubMed » Google
Scholar

42. Werness BA, Levine AJ, Howley PM (1990) Association of human

J Cancer Sci Ther

Volume 1(2) : 062-071 (2009) - 071
ISSN:1948-5956 JCST, an open access journal

